Canadian Pharmaceuticals & Biotech Most Popular Stocks

Curaleaf Holdings

Market Cap: CA$3.4b

Produces and distributes cannabis products in the United States and internationally.

Green Thumb Industries

Market Cap: CA$2.7b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Trulieve Cannabis

Market Cap: CA$2.3b

Operates as a cannabis retailer.

Cronos Group

Market Cap: CA$1.6b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

Cresco Labs

Market Cap: CA$836.8m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.

Vireo Growth

Market Cap: CA$826.4m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, and New York.

Verano Holdings

Market Cap: CA$745.3m

Operates as a vertically integrated multi-state cannabis operator in the United States.

Canopy Growth

Market Cap: CA$686.4m

Engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia.

Knight Therapeutics

Market Cap: CA$590.0m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

Bright Minds Biosciences

Market Cap: CA$581.3m

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

TerrAscend

Market Cap: CA$495.4m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Aurora Cannabis

Market Cap: CA$488.9m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

High Tide

Market Cap: CA$456.5m

Engages in the cannabis retail business in Canada.

Spectral Medical

Market Cap: CA$437.7m

Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.

Cipher Pharmaceuticals

Market Cap: CA$397.8m

Operates as a specialty pharmaceutical company in Canada.

Eupraxia Pharmaceuticals

Market Cap: CA$390.5m

A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.

Organigram Global

Market Cap: CA$368.1m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

NervGen Pharma

Market Cap: CA$241.8m

A biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.

Theratechnologies

Market Cap: CA$215.6m

A biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe.

Auxly Cannabis Group

Market Cap: CA$202.3m

Operates as a consumer packaged goods company in the cannabis products market in Canada.

HLS Therapeutics

Market Cap: CA$177.4m

A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally.

Grown Rogue International

Market Cap: CA$149.7m

A craft cannabis company, focuses on premium flower and flower-derived products.

BioSyent

Market Cap: CA$132.7m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

Cardiol Therapeutics

Market Cap: CA$132.3m

A clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

Satellos Bioscience

Market Cap: CA$127.8m

A biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.

Helix BioPharma

Market Cap: CA$121.4m

Operates as an immune-oncology company in Canada.

Planet 13 Holdings

Market Cap: CA$118.8m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

ME Therapeutics Holdings

Market Cap: CA$118.4m

A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.

InnoCan Pharma

Market Cap: CA$117.4m

A pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally.

Atlas Energy

Market Cap: CA$107.0m

A biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States.

BioNxt Solutions

Market Cap: CA$104.2m

Engages in research, development, manufacture, and sale of next generation drug formulations and delivery systems in Austria, Germany, and Switzerland.

Vext Science

Market Cap: CA$90.4m

Through its subsidiaries, provides integrated agricultural technology, services, and property management services in the cannabis industry in the United States.

Onco-Innovations

Market Cap: CA$90.1m

A pre-clinical stage biotechnology company, develops drug candidates for cancer treatments.

TRUBAR

Market Cap: CA$87.3m

Operates as a consumer products company with diversified assets in the plant-based and wellness consumer product categories in Canada.

Medexus Pharmaceuticals

Market Cap: CA$86.9m

Operates as a pharmaceutical company in Canada and the United States.

Quantum BioPharma

Market Cap: CA$85.9m

Operates as a biopharmaceutical company.